Pulmonary embolism and deep vein thrombosis.
Goldhaber SZ, Bounameaux H.
Lancet. 2012 May 12;379(9828):1835-46. doi: 10.1016/S0140-6736(11)61904-1. Epub 2012 Apr 10.
Increased plasma DR-70 (fibrinogen-fibrin degradation products) concentrations as a diagnostic biomarker in dogs with neoplasms.
Ke CH, Sio KM, Wu CH, Xia YY, Lee JJ, Hu CH, Liu CC, Lu CL, Cheng CL, Lin KH, Tomiyasu H, Wang YS, Lin CS.
J Vet Intern Med. 2023 Nov-Dec;37(6):2391-2401. doi: 10.1111/jvim.16898. Epub 2023 Oct 14.
A randomized trial of safety, pharmacokinetics and pharmacodynamics of concizumab in people with hemophilia A.
Eichler H, Angchaisuksiri P, Kavakli K, Knoebl P, Windyga J, Jiménez-Yuste V, Hyseni A, Friedrich U, Chowdary P.
J Thromb Haemost. 2018 Nov;16(11):2184-2195. doi: 10.1111/jth.14272. Epub 2018 Sep 30.
[Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria].
Ito K, Wada H, Abe Y, Tomatsu H, Nishioka J, Nobori T.
Rinsho Byori. 2003 Apr;51(4):295-9.
Fibrinogen degradation products in plasma following induced hyperfibrinolysis.
Chek JB, Panchenko NI.
East Afr Med J. 2000 Apr;77(4):217-20.
Influence of fibrinogen degradation products on thrombin time, activated partial thromboplastin time and prothrombin time of canine plasma.
Mischke R, Wolling H.
Haemostasis. 2000 May-Jun;30(3):123-30. doi: 10.1159/000022534.
D-dimers (DD) in CVST.
Wang HF, Pu CQ, Yin X, Tian CL, Chen T, Guo JH, Shi Q.
Int J Neurosci. 2017 Jun;127(6):524-530. doi: 10.1080/00207454.2016.1207172. Epub 2016 Jul 17.
Fibrin and fibrinogen degradation products in plasma of patients with colorectal adenocarcinoma.
Okholm M, Iversen LH, Thorlacius-Ussing O, Ejlersen E, Boesby S.
Dis Colon Rectum. 1996 Oct;39(10):1102-6. doi: 10.1007/BF02081408.
Measuring plasma fibrinogen levels in patients with liver cirrhosis. The occurrence of proteolytic fibrin(ogen) degradation products and their influence on several fibrinogen assays.
de Maat MP, Nieuwenhuizen W, Knot EA, van Buuren HR, Swart GR.
Thromb Res. 1995 May 15;78(4):353-62. doi: 10.1016/0049-3848(95)91463-u.
[Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
Imoto K, Yasumuro Y, Taki M, Suzuki N, Tanabe H, Ichikawa Y.
Rinsho Byori. 2001 Mar;49(3):283-9.
